MedTrace Logo

Analysis of Blood Metabolomics to Identify Potential Biomarkers of Gastrointestinal Bleeding

NCT05547360 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2022-09-21

No results posted yet for this study

Summary

Despite advances in gastrointestinal endoscopy and pharmaceuticals, gastrointestinal bleeding is still a significant emergency disease with a high mortality rate of 1.9-5 per 100 people due to excessive bleeding and shock.

There are several indicators using pulse rate, blood pressure, hemoglobin, etc. to select patients who require endoscopic intervention, or hospitalization, but these are inaccurate and with a high false-positive rate and low specificity at 35-40%.

Therefore, tests with high diagnostic accuracy for gastrointestinal bleeding patients are required and findings specific biomarkers for gastrointestinal bleeding are of great importance.

Conditions

  • GastroIntestinal Bleeding

Sponsors & Collaborators

Principal Investigators

  • Jung Eun Kim, Ph.D · National University of Singapore (Food Science and Technology)

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-19
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05547360 on ClinicalTrials.gov